Sign In
Buy ABBV
$217.07
+1.64 (+0.761%)
At Close: Jun 03, 2026
Rep. Julia Letlow Purchases Shares of The Walt Disney Company (NYSE:DIS)
02:06am, Thursday, 15'th Jan 2026
Representative Julia Letlow (R-Louisiana) recently bought shares of The Walt Disney Company (NYSE: DIS). In a filing disclosed on January 13th, the Representative disclosed that they had bought betwee
Rep. Julia Letlow Sells Off Shares of Pinterest, Inc. (NYSE:PINS)
02:06am, Thursday, 15'th Jan 2026
Representative Julia Letlow (R-Louisiana) recently sold shares of Pinterest, Inc. (NYSE: PINS). In a filing disclosed on January 13th, the Representative disclosed that they had sold between $1,001 an
Rep. Julia Letlow Sells Warner Bros. Discovery, Inc. (NASDAQ:WBD) Shares
02:06am, Thursday, 15'th Jan 2026
Representative Julia Letlow (R-Louisiana) recently sold shares of Warner Bros. Discovery, Inc. (NASDAQ: WBD). In a filing disclosed on January 13th, the Representative disclosed that they had sold bet
Rep. Julia Letlow Purchases Shares of Devon Energy Corporation (NYSE:DVN)
02:06am, Thursday, 15'th Jan 2026
Representative Julia Letlow (R-Louisiana) recently bought shares of Devon Energy Corporation (NYSE: DVN). In a filing disclosed on January 13th, the Representative disclosed that they had bought betwe
AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
05:45pm, Wednesday, 14'th Jan 2026
AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AbbVie plans to build out its presence in obesity market
02:01pm, Wednesday, 14'th Jan 2026
AbbVie said on Wednesday it is seeking to expand its presence in the fast-growing market for obesity treatments, leaning on the weight-loss drug it licensed last year from Danish biotech Gubra.
Wall Street Bulls Look Optimistic About AbbVie (ABBV): Should You Buy?
10:30am, Wednesday, 14'th Jan 2026
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
First Look: Alphabet $4T, Nvidia China OK, Boeing Tops Airbus
07:39am, Wednesday, 14'th Jan 2026
Stock News Saks Global files Chapter 11: Saks Global (private) sought Chapter 11 protection, citing heavy debt from its 2024 Neiman Marcus deal and inventory st
ABBV Inks Drug Pricing Deal With Trump, Joins PD-1xVEGF Bandwagon
01:36pm, Tuesday, 13'th Jan 2026
AbbVie strikes a Trump drug-pricing pact and a $5.6B cancer licensing deal, cutting U.S. prices while expanding its oncology pipeline.
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 13'th Jan 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
10:01am, Tuesday, 13'th Jan 2026
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Will AbbVie's Oncology Segment Support Top-line Growth in Q4 Earnings?
09:46am, Tuesday, 13'th Jan 2026
ABBV's oncology unit is expected to post nearly 4% Q4 sales growth, as newer drugs offset weakness from declining Imbruvica demand.
AbbVie Secures Tariff Relief Pact
08:22am, Tuesday, 13'th Jan 2026
AbbVie (ABBV) has reached a new agreement with the Trump administration that lowers drug prices while giving the company tariff relief and more visibility on lo
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines
08:09am, Tuesday, 13'th Jan 2026
AbbVie agrees to lower drug prices, invest $100 billion in the U.S., expand manufacturing, and secure tariff relief.
First Look: Fed Probe, Bank Cap Shock, Gold Soars, Deals
07:38am, Tuesday, 13'th Jan 2026
Stock News DOJ subpoenas Fed chair spark backlash: Federal prosecutors served grand jury subpoenas to Jerome Powell over testimony on Fed HQ renovations, prompt
